AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 29.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
AnGes Market Cap
AnGes has a market cap or net worth of 11.17 billion as of October 26, 2026. It is the 27,536th most valuable company in the world and the 2,423rd biggest in Japan. Its market cap has decreased by 63.31% in one year.
Market Cap
11.17B
Enterprise Value
11.61B
Revenue
962.00M
Global Rank
Country Rank
#2,423 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 11.17B, a decrease of -52.20%. That is a compound annual growth rate of -3.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 11.57B | -51.07% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 16.22B |
| Stella Pharma | 14.67B |
| CanBas | 14.07B |
| ReproCELL | 12.67B |
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |
| StemRIM | 9.28B |
| Carna Biosciences | 8.18B |